Decoding Nvidia CEO’s Visit to Shanghai: Impact on Gaming, Graphics, and AI Processor Market

Nvidia Corp (NASDAQ: NVDA) CEO Jensen Huang could visit Shanghai, the first visit in four years. Despite escalating geopolitical tensions, Nvidia CEO Jensen Huang may visit Shanghai on June 6.
  • Nvidia Corp (NASDAQ:NVDA) CEO Jensen Huang could visit Shanghai, the first visit in four years.
  • Despite escalating geopolitical tensions, Nvidia CEO Jensen Huang may visit Shanghai on June 6.
  • Huang may meet executives from Tencent Holding Ltd (OTC:TCEHY), TikTok owner ByteDance Ltd, smartphone giant Xiaomi Corp (OTC:XIACY) (OTC:XIACF), and automobile makers BYD Co, Ltd (OTC: BYDDF) (OTC: BYDDY) and Li Auto Inc (NASDAQ: LI), SCMP reports.
  • The Taiwan-born American entrepreneur spent this week in Taiwan, having dinner with Morris Chang, founder of Taiwan Semiconductor Manufacturing Company Ltd (NYSE: TSM). 
  • Huang will likely meet the chairman of TSMC and Apple Inc (NASDAQ:AAPL) supplier Hon Hai Precision Industry Co Ltd (OTC: HNHPF) Foxconn Technology Group on Friday.
  • Huang expressed immense confidence in China’s ability to catch up in chip technology despite the U.S. embargo at the Computex expo in Taipei.
  • Huang had flagged immense damage to U.S. tech from its semiconductor chip embargo with China, one of the company’s biggest and most important markets.
  • Huang said China made up roughly 33.33% of the U.S. tech industry’s market and would be indispensable as both a source of components and an end market for its products.
  • China, including Hong Kong, accounted for more than 20% of Nvidia’s sales in its latest financial year ending January 2023, while Taiwan represented more than 25%. 
  • He emphasized how Chinese companies built their chips to rival Nvidia’s market-leading gaming, graphics, and artificial intelligence processors.
  • Nvidia had altered its flagship product into a legal version to export to China.
  • Price Action: NVDA shares traded higher by 1.33% at $402.99 premarket on the last check Friday.
  • Photo via Wikimedia Commons
Total
0
Shares
Related Posts
Read More

Drug Shortages in Focus: How FDA’s Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape

The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March.  Methotrexate is an injected medication utilized to treat various cancers and autoimmune diseases like rheumatoid arthritis, as stated by the National Cancer Institute.

HKMPF

Read More

What’s Going On Applied UV Shares Tuesday?

AUVI shares drop by 21.5% despite positive signals of $10 million 2024 sales from LED Supply Co. investments. Applied UV's groundbreaking Fighter Flex LED solution, unveiled at AHR Expo, promises to redefine energy efficiency in HVAC systems. CEO Max Munn highlights Smart Building Technologies' acquisitions paying off as 2024 marks a pivotal financial juncture.

AUVI